A case report of a chronic migraine patient treated with three different anti-CGRP monoclonal antibodies: which parameters better represent the efficacy?

OBJECTIVE: To report the efficacy of different anti-calcitonin gene-related peptide (CGRP) monoclonal antibodies (mAbs) on headache frequency, intensity, and duration. BACKGROUND: Blockade of CGRP receptors or neuropeptide with anti-CGRP mAbs have been successfully used for several years for the pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Uzun, Sena, Frejvall, Ulf, Özkaya-Sahin, Gülsen, Sahin, Gürdal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10198612/
https://www.ncbi.nlm.nih.gov/pubmed/37213912
http://dx.doi.org/10.3389/fneur.2023.1176816

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10198612/
https://www.ncbi.nlm.nih.gov/pubmed/37213912
http://dx.doi.org/10.3389/fneur.2023.1176816

Ejemplares similares